MHC class I chain-related gene B promoter polymorphisms and celiac disease. 2006

Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
Department of Functional Biology, University of Oviedo, Spain.

The possibility that susceptibility to celiac disease (CD) might be influenced by the MHC class I chain-related gene family, MICA and MICB, has been previously reported. In this study, we analyzed the MICB promoter and examined the association of the polymorphisms found within such in a group of CD patients. To study the MICB promoter we sequenced the 5' flanking region of MICB gene in DNA from homozygous B-lymphoblastoid cell lines corresponding to the most frequent MICB alleles found in our population (MICB*00502, MICB*002, MICB*004, and MICB*008). DNA from a MICB*003 homozygous individual was also analyzed. Sequence analysis revealed six single nucleotide polymorphisms located at positions 45860 C/A, 45862 G/C, 45877 C/G, 46113 A/C, 46219 G/C, and 46286 G/C and an insertion of 2 bp --/AG at position 45944 according to the published genomic sequence. Those polymorphisms were found to be associated in four different haplotypes corresponding to different MICB alleles. Subsequently, 126 CD subjects and 117 healthy controls were typed by polymerase chain reaction using sequence-specific primers for these polymorphisms. MICB promoter polymorphism haplotypes were also found in our population and showed strong linkage disequilibrium with MICB alleles. MICB promoter polymorphism Haplotype 3, included in MICB*002 and MICB*008 alleles, was found to be overrepresented in CD patients (79.4% CD patients vs 45.3% healthy controls; p(c) < 0.0001; OR = 4.64; CI 95% = 2.64-8.16). Both MICB*008 and MICB*002 alleles were found as part of the CD susceptibility extended haplotypes B8/DR3/DQ2, B18/DR3/DQ2, and DR4/DQ8.

UI MeSH Term Description Entries
D008297 Male Males
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002446 Celiac Disease A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION. Gluten Enteropathy,Sprue, Celiac,Sprue, Nontropical,Celiac Sprue,Gluten-Sensitive Enteropathy,Sprue,Disease, Celiac,Enteropathies, Gluten,Enteropathies, Gluten-Sensitive,Enteropathy, Gluten,Enteropathy, Gluten-Sensitive,Gluten Enteropathies,Gluten Sensitive Enteropathy,Gluten-Sensitive Enteropathies,Nontropical Sprue
D005260 Female Females
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
May 2014, Tissue antigens,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
February 2016, International journal of immunogenetics,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
December 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
June 2015, International journal of immunogenetics,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
March 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
January 1997, Immunogenetics,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
March 2007, Rheumatology (Oxford, England),
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
April 2003, Tissue antigens,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
January 2015, PloS one,
Sandra Rodriguez-Rodero, and Luis Rodrigo, and Juan Luis Fdez-Morera, and Jesus Martinez-Borra, and Antonio Lopez-Vázquez, and Dolores Fuentes, and Ruben Lopez-Arbesu, and Alejandro Lopez-Soto, and Segundo Gonzalez, and Carlos Lopez-Larrea
January 2009, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!